Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2003
11/13/2003WO2003092631A2 Cyclic peptide anti-viral agents and methods
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003048190A3 Acyclovir-peptide analogs
11/13/2003WO2003022871A3 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003US20030212253 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212002 Peptide for controlling appetite
11/13/2003US20030211980 Antibody; controlling cell activation
11/13/2003US20030211973 Polyglutamic acid-camptothecin conjugates and methods of preparation
11/13/2003US20030211560 Bioluminescent protease assay
11/13/2003US20030211471 Method for detecting ligands and targets in a mixture
11/13/2003CA2489009A1 Connective tissue stimulating peptides
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/12/2003EP1361228A1 Thermostable and monoconjugatable gold cluster complexes
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360189A1 Formulation of boronic acid compounds
11/12/2003EP1359934A2 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP0871454B1 Phosphorous-containing cysteine and serine protease inhibitors
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003CN1455780A New retinol derivatives, method of preparation and uses thereof
11/12/2003CN1454494A Albumen oligo peptide and preparing method thereof
11/12/2003CN1127513C Phosphonic acid derivatives with metallopeptidase inhibitory activity
11/12/2003CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127497C Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
11/12/2003CN1127488C Compouds with growth hormone releasing properties
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003CA2264268C Novel peptide derivatives having thiazolyl-alanine residue
11/11/2003CA2185932C Use of a least one peptide in a cosmetic composition or for the preparation of a drug
11/06/2003WO2003091278A1 Gamma-secretase inhibitors
11/06/2003WO2003076458A3 Selective dipeptide inhibitors of kallikrein
11/06/2003WO2003053999A3 Selective arylguanidine peptides as urokinase inhibitors
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030208037 Novel fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030207814 Novel guanidinyl derivatives
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207344 Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins
11/06/2003US20030207324 Immunotherapy by modulation of antigen presentation
11/05/2003EP1358205A2 Tetrapeptidic tryptase substrates and assay for tryptase activity using same
11/05/2003EP1358204A1 Tripeptide derivatives for the treatment of neurodegenerative diseases
11/05/2003EP1358200A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
11/05/2003EP1358163A1 Melanocortin receptor agonists
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone
11/04/2003US6642406 Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using L-α-aspartyl-L-phenylalanine 1-methyl ester precursors
11/04/2003US6642388 Method for producing 2-aminomethyl-4-cyano-thiazol
11/04/2003US6642355 Endothelin-antagonizing peptide
11/04/2003US6642269 Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
11/04/2003US6642253 Thrombin inhibitors comprising an aminoisoquinoline group
11/04/2003US6642204 Inhibitors of hepatitis C virus NS3 proteases; inhibit RNA replication
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/04/2003CA2094773C 2,4-dioxoimidazolidine derivatives
10/2003
10/30/2003WO2003089922A1 Method for detecting ligands and targets in a mixture
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089459A2 Thyrotropin-releasing hormone analogues and their therapeutic applications
10/30/2003WO2003089455A2 Low-cost production of peptides
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003088990A1 Plasma protein-binding ligands
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003053996A3 Modular peptide-based reagent
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2002085847A3 Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203851 Substituted oxadiazole, peptoids which are useful for treating adult respiratory distress syndrome, septic shock and myocardial ischemia-reperfusion injury
10/30/2003CA2482995A1 Low-cost production of peptides
10/30/2003CA2482856A1 Plasma protein-binding ligands
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482529A1 Method for detecting ligands and targets in a mixture
10/29/2003EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis
10/29/2003EP1355965A2 Block copolymers for multifunctional self-assembled systems
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355674A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors
10/29/2003EP1105404B1 Purification of oligomers using dual-end selection
10/29/2003EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
10/29/2003EP0946526B1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/29/2003CN1452632A Extended native chemical ligation
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/28/2003US6639075 Lactam-aldehyde compound and process of preparing same
10/28/2003US6638941 Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domains
10/28/2003US6638911 Modulating agents comprise one or more of a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; a non-peptide mimetic of a desmosomal cadherin CAR sequence; a substance, such as an antibody or antigen binding
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 307